Findings

What do systematic reviews say?

761 questions · 801 findings · 50 reviews · Common Mental Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 125 · 15.6%GRADE not reported 34 · 4.2%Very low 226 · 28.2%Low 232 · 29%Moderate 176 · 22%High 8 · 1%

Behavioural activation vs no treatment

quality of life (continuous)up to 6 months (2 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 118 participants
High

Behavioural activation vs no treatment

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Behavioural activation vs treatment

treatment efficacyup to 6 months (5‐12 weeks) · depression in adults

Behavioural activation probably leads to higher treatment efficacyup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 1.4 [1.1, 1.79]
7 studies · 1533 participants
Moderate

Behavioural activation vs treatment

treatment acceptabilityup to 6 months (5‐12 weeks) · depression in adults

Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 1.64 [0.81, 3.31]
14 studies · 2518 participants
Moderate

Behavioural activation vs treatment

depression symptoms (continuous) up to 6 months (4‐8 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
15 studies · 2208 participants
Low

Behavioural activation vs treatment

quality of life (continuous)up to 6 months (2 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1299 participants
Very low

Behavioural activation vs treatment

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 88 participants
Low

Behavioural activation vs treatment

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1063 participants
Moderate

Behavioural activation vs treatment

adverse events(8‐10 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1471 participants
Moderate

Behavioural activation vs CBT

social adjustment and functioning (continuous)up to 6 months (12 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 111 participants
Very low

Behavioural activation vs CBT

Anxiety · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 646 participants
Moderate

Behavioural activation vs CBT

adverse events (16 weeks) · depression in adults

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 398 participants
Moderate

Behavioural activation vs third‐wave CBT

treatment efficacy up to 6 months (4‐8 weeks) · depression in adults

Behavioural activation showed no clear difference in treatment efficacy up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 1.1 [0.91, 1.33]
2 studies · 98 participants
Low

Behavioural activation vs third‐wave CBT

Secondary outcome: acceptability of treatment · depression in adults

Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults 2020 · Cochrane Headline outcomes only
RR 0.84 [0.33, 2.1]
3 studies · 147 participants
Low

Behavioural activation vs any comparator

Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases

Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.53 [0.98, 2.38]
2 studies · 176 participants
Low

Behavioural activation vs any comparator

Quality of life (medium term: 12 months) · depression in adults with non‐communicable diseases

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases

2 findings from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low
Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases

2 findings from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low
Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Behavioural activation vs any comparator

Treatment efficacy for depression (medium term: 12 months) · depression in adults with non‐communicable diseases

Behavioural activation probably leads to higher treatment efficacy for depression (medium term: 12 months) compared with any comparator (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.76 [1.01, 3.08]
1 study · 92 participants
Moderate

Behavioural activation vs any comparator

Treatment efficacy for depression (long term: 24 months) · depression in adults with non‐communicable diseases

Behavioural activation showed no clear difference in treatment efficacy for depression (long term: 24 months) compared with any comparator (moderate certainty).

1 finding from 1 review

Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
RR 1.42 [0.91, 2.23]
1 study · 67 participants
Moderate